In general, CSC marker-positive cells (CD133+, CD44+, CD166+, aldehyde dehydrogenase (ALDH+), and epithelial cell adhesion molecule (EpCAM+)) exhibit a 100-fold increased capacity to initiate cancer [6]. This evidence concerns the gene EPCAM and cancer.